{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:31:38Z","timestamp":1787239898046,"version":"build-2736575974"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Challenges providing outpatient parenteral antimicrobial therapy (OPAT) can compromise patient safety and care quality, yet little is known about how OPAT is delivered by health care systems across the US.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To understand and compare OPAT delivery at US Department of Veterans Affairs Medical Centers (VAMCs).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This qualitative study using a mixed-methods approach was performed from February 6, 2024, through April 15, 2025. Six midwestern VAMCs were purposively selected, identifying physician and pharmacist leaders to participate in qualitative interviews via an antimicrobial stewardship listserv, and other participants involved in OPAT delivery were identified via snowball sampling. The VAMCs for the quantitative survey were identified through the 2020 Veterans Health Administration Antimicrobial Stewardship National Survey.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Semistructured clinician interviews focused on OPAT decision-making, patient education, care coordination, and postdischarge management. Organizational surveys assessed OPAT program structure, characteristics, and care delivery challenges. After a structured rapid qualitative analysis and generation of descriptive statistics, findings were evaluated together.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Interviews were conducted with 31 participants from 6 VAMCs. Key informants from 106 of 139 VAMCs (76.3%) completed surveys. All participants were actively engaged in OPAT care at the time of data collection. Interviews showed heterogeneity in OPAT processes across medical centers, with challenges involving communication, coordination, support, and uncertainty about roles and responsibilities, particularly among sites without a designated OPAT team. Of 78 surveyed VAMCs (73.6%) offering OPAT, 60 (76.9%) identified designated persons who managed OPAT. Most facilities evaluated OPAT appropriateness (75 [96.2%]) and used contract pharmacy (72 [92.3%]) and contract nursing (62 [79.5%]) to deliver OPAT care, although primary responsibility for outpatient monitoring varied.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study found that VAMC OPAT care processes were highly variable. Although a knowledgeable and interdisciplinary team may be ideal, having such a team may not always be possible due to staffing and cost constraints. Developing facility-level OPAT-dedicated processes, including policies and checklists, as well as increased support and protected time for staff may improve safe, effective OPAT delivery in VAMCs.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.29952","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:01:14Z","timestamp":1787238074000},"page":"e2629952","source":"Crossref","is-referenced-by-count":0,"title":["Outpatient Parenteral Antimicrobial Therapy Practice Variability Across Veterans Affairs Hospitals"],"prefix":"10.1001","volume":"9","author":[{"given":"Elizabeth A.","family":"Scruggs-Wodkowski","sequence":"first","affiliation":[{"name":"Infectious Diseases Section, Department of Internal Medicine, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Michigan Medicine, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Gauntlett","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Helminski","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Blok","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"University of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor"},{"name":"University of Michigan School of Nursing, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Henry","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Keller","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Kendall","sequence":"additional","affiliation":[{"name":"Infectious Diseases Section, Department of Internal Medicine, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Nitta","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Ranusch","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milisa","family":"Manojlovich","sequence":"additional","affiliation":[{"name":"University of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor"},{"name":"University of Michigan School of Nursing, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Harrod","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Krein","sequence":"additional","affiliation":[{"name":"VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"University of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor"},{"name":"Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"1","key":"zoi260821r2","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.313","article-title":"Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: a retrospective cohort study.","volume":"2","author":"Kaul","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"3","key":"zoi260821r3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1017\/ice.2023.216","article-title":"Factors associated with loss to follow-up in outpatient parenteral antimicrobial therapy: a retrospective cohort study.","volume":"45","author":"Kaul","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"zoi260821r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106911","article-title":"Risk of venous thromboembolism in outpatient parenteral antimicrobial therapy (OPAT): a systematic review and meta-analysis.","volume":"62","author":"Durojaiye","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"zoi260821r5","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf075","article-title":"Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey.","volume":"7","author":"Wolie","year":"2025","journal-title":"JAC Antimicrob Resist"},{"issue":"5","key":"zoi260821r6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/antibiotics14050451","article-title":"Delivery of outpatient parenteral antimicrobial therapy (OPAT) in an ever-changing National Health Service (UK): benefits, barriers, and opportunities.","volume":"14","author":"Durojaiye","year":"2025","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"zoi260821r7","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae111","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn?","volume":"6","author":"Reidy","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"zoi260821r8","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2026.10347","article-title":"Management of outpatient parenteral antibiotic therapy: a United States-based multi-center survey.","volume":"6","author":"Castellino","year":"2026","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"9","key":"zoi260821r10","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/cid\/ciac513","article-title":"Mind the OPAT Gap: providing home intravenous antibiotic therapy for veterans hospitalized at community hospitals.","volume":"75","author":"Storey","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260821r12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy745","article-title":"2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy.","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi260821r13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/cid\/ciz362","article-title":"Quality indicators for appropriate outpatient parenteral antimicrobial therapy in adults: a systematic review and RAND-modified Delphi procedure.","volume":"70","author":"Berrevoets","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"zoi260821r14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"key":"zoi260821r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.apergo.2019.103033","article-title":"SEIPS 3.0: human-centered design of the patient journey for patient safety.","volume":"84","author":"Carayon","year":"2020","journal-title":"Appl Ergon"},{"issue":"Suppl 1","key":"zoi260821r17","doi-asserted-by":"publisher","first-page":"i50","DOI":"10.1136\/qshc.2005.015842","article-title":"Work system design for patient safety: the SEIPS model.","volume":"15","author":"Carayon","year":"2006","journal-title":"Qual Saf Health Care"},{"issue":"1","key":"zoi260821r18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/00365548.2014.967290","article-title":"A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).","volume":"47","author":"Muldoon","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"zoi260821r19","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231214901","article-title":"Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.","author":"Hassanzai","year":"2023","journal-title":"Ther Adv Infect Dis"},{"issue":"10","key":"zoi260821r20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3390\/antibiotics11101343","article-title":"Current practices and opportunities for outpatient parenteral antimicrobial therapy in hospitals: a national cross-sectional survey.","volume":"11","author":"Stoorvogel","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"zoi260821r21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1086\/676859","article-title":"Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians.","volume":"35","author":"Lane","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"zoi260821r22","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz363","article-title":"Perspectives of United States-based infectious diseases physicians on outpatient parenteral antimicrobial therapy practice.","volume":"6","author":"Hamad","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"zoi260821r23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad372","article-title":"Perspectives on the use of outpatient parenteral antibiotic therapy for people who inject drugs: results from an online survey of infectious diseases clinicians.","volume":"10","author":"Solomon","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"zoi260821r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106559","article-title":"Survey of delivery of parenteral antimicrobials in non-inpatient settings across Europe.","volume":"59","author":"Emilie","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"zoi260821r25","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.40","article-title":"Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United States.","volume":"2","author":"Rivera","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"43","key":"zoi260821r27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse.","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"12","key":"zoi260821r28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi260821r29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/cid\/cit211","article-title":"Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence.","volume":"57","author":"Muldoon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260821r30","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.330","article-title":"Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program.","volume":"3","author":"Agnihotri","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"7","key":"zoi260821r31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/cid\/ciy674","article-title":"Infectious diseases specialty intervention is associated with better outcomes among privately insured individuals receiving outpatient parenteral antimicrobial therapy.","volume":"68","author":"Shah","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi260821r32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/cid\/ciaf146","article-title":"Quantifying and financing the nonbillable workload of outpatient parenteral antimicrobial therapy (OPAT)-A model for assessing and supporting staffing needs for OPAT Programs.","volume":"80","author":"Yamshchikov","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260821r33","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.476","article-title":"We\u2019ll take it from here: Veterans Affairs OPAT management of home IV therapy initiated at community hospitals.","volume":"3","author":"Tiemann","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"1","key":"zoi260821r34","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2025.10133","article-title":"Antimicrobial tele-stewardship strategies and their application to the rural outpatient setting.","volume":"5","author":"Peworchik","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"4","key":"zoi260821r35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.idc.2023.07.005","article-title":"Health system and tele-antimicrobial stewardship: the role of building networks.","volume":"37","author":"Kassamali Escobar","year":"2023","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"zoi260821r36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/antibiotics13050420","article-title":"A qualitative review of patient feedback for the OPAT (outpatient antimicrobial therapy) service in Bristol.","volume":"13","author":"Soni","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"zoi260821r37","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx097","article-title":"Bundle in the Bronx: impact of a transition-of-care outpatient parenteral antibiotic therapy bundle on all-cause 30-day hospital readmissions.","volume":"4","author":"Madaline","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"zoi260821r9","volume-title":"2020 Survey of Antimicrobial Stewardship in VHA Report","author":"Mattison Brown","year":"2022"},{"key":"zoi260821r15","volume-title":"Facilities Staffing Requirements for the Veterans Health Administration\u2013Resource Planning and Methodology for the Future","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"zoi260821r26","volume-title":"Qualitative Methods in Rapid Turn-Around Health Services Research","author":"Hamilton","year":"2013"},{"key":"zoi260821r1","unstructured":"About home and alternate site infusion. National Home Infusion Association. 2021. Accessed June 24, 2025. https:\/\/nhia.org\/about-infusion-therapy\/"},{"key":"zoi260821r11","unstructured":"Shah? A, Norris? A, eds. Handbook of Outpatient Parenteral Antimicrobial Therapy (OPAT). CRG Publishing; 2016. Accessed July 14, 2025. https:\/\/www.idsociety.org\/globalassets\/idsa\/clinical-affairs\/opat_epub_finalv3.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2853097\/scruggswodkowski_2026_oi_260821_1786641283.80525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:01:23Z","timestamp":1787238083000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2853097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.29952","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}